L-asparaginase bulk supplier for pharma manufacturers

L-Asparaginase Suppliers & Bulk Manufacturers

Available Forms: IV Infusion and IV/ IM Injection

Available Strengths: 10,000 IU/vial (IV or IM injection); 2,500 IU/vial (IV infusion)

Reference Brands: Elspar® , Asparlas®, Erwinase® (US & EU)

L-asparaginase is used to treat acute lymphoblastic leukemia (ALL) and lymphomas by depleting the amino acid asparagine. Available under brands like Elspar®, Asparlas®, and Erwinase®, it comes in strengths such as 10,000 IU/vial and 2,500 IU/vial. Administered via IV or IM injection, it is widely sourced by B2B pharmaceutical wholesalers in the US and EU, ensuring reliable, GMP-compliant supply and competitive pricing for oncology centers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: L-asparaginase is an essential enzyme-based chemotherapy used in the treatment of acute lymphoblastic leukemia (ALL) and lymphomas. It works by depleting asparagine, an amino acid needed for cancer cell survival. Available under brands like Elspar®, Asparlas®, and Erwinase®, it is offered in strengths such as 10,000 IU/vial and 2,500 IU/vial. Administered via intravenous (IV) or intramuscular (IM) injection, L-asparaginase is widely sourced by B2B pharmaceutical wholesalers in the US and EU. These therapies ensure reliable GMP-compliant distribution for oncology centers, offering competitive pricing and consistent supply for cancer treatment.

L-Asparaginase — third party manufacturing & bulk supply

L-Asparaginase is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

L-Asparaginase is supplied as IV Infusion and IV/ IM Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of L-Asparaginase listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for L-Asparaginase →

Back to Listing

Frequently Asked Questions

L-asparaginase is listed as IV Infusion and IV/ IM Injection in 10,000 IU/vial (IV or IM injection); 2,500 IU/vial (IV infusion). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

L-asparaginase is referenced against Elspar® , Asparlas®, Erwinase® (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.